Invention Grant
- Patent Title: Hydrocortisone controlled release formulation
-
Application No.: US14374179Application Date: 2013-02-12
-
Publication No.: US09750704B2Publication Date: 2017-09-05
- Inventor: Hiep Huatan , Richard Ross , Martin Whitaker
- Applicant: Diurnal Limited
- Applicant Address: GB Cardiff
- Assignee: Diurnal Limited
- Current Assignee: Diurnal Limited
- Current Assignee Address: GB Cardiff
- Agency: Klarquist Sparkman, LLP
- Priority: GB1202433.7 20120213
- International Application: PCT/GB2013/050311 WO 20130212
- International Announcement: WO2013/121184 WO 20130822
- Main IPC: A61K9/50
- IPC: A61K9/50 ; A61K31/573
Abstract:
The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.
Public/Granted literature
- US20140370113A1 HYDROCORTISONE CONTROLLED RELEASE FORMULATION Public/Granted day:2014-12-18
Information query
